Genetic Analysis Past Earnings Performance
Past criteria checks 0/6
Genetic Analysis's earnings have been declining at an average annual rate of -3.4%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 22.2% per year.
Key information
-3.4%
Earnings growth rate
15.4%
EPS growth rate
| Biotechs Industry Growth | 0.7% |
| Revenue growth rate | 22.2% |
| Return on equity | -87.6% |
| Net Margin | -104.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Genetic Analysis makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 20 | -21 | 18 | 0 |
| 30 Jun 24 | 21 | -22 | 18 | 0 |
| 31 Mar 24 | 22 | -22 | 19 | 0 |
| 31 Dec 23 | 23 | -24 | 21 | 0 |
| 30 Sep 23 | 22 | -25 | 22 | 0 |
| 30 Jun 23 | 22 | -27 | 22 | 0 |
| 31 Mar 23 | 22 | -28 | 23 | 0 |
| 31 Dec 22 | 21 | -28 | 22 | 0 |
| 30 Sep 22 | 23 | -28 | 22 | 0 |
| 30 Jun 22 | 20 | -28 | 23 | 0 |
| 31 Mar 22 | 17 | -29 | 21 | 0 |
| 31 Dec 21 | 13 | -29 | 20 | 0 |
| 30 Sep 21 | 9 | -30 | 19 | 0 |
| 30 Jun 21 | 8 | -27 | 17 | 0 |
| 31 Mar 21 | 7 | -25 | 16 | 0 |
| 31 Dec 20 | 8 | -22 | 15 | 0 |
| 31 Dec 19 | 11 | -7 | 12 | 0 |
| 31 Dec 18 | 5 | -22 | 11 | 0 |
| 31 Dec 17 | 3 | -20 | 8 | 0 |
Quality Earnings: GEAN is currently unprofitable.
Growing Profit Margin: GEAN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GEAN is unprofitable, and losses have increased over the past 5 years at a rate of 3.4% per year.
Accelerating Growth: Unable to compare GEAN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GEAN is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).
Return on Equity
High ROE: GEAN has a negative Return on Equity (-87.56%), as it is currently unprofitable.